NCT00482196View on ClinicalTrials.gov

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Enrollment

173

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Obesity

Interventions

DRUG

MK0493

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482196 - To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED) | Biotech Hunter | Biotech Hunter